Simple card may help parents detect jaundice in newborns
NCT ID NCT07386093
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving families a skin color monitoring card (S-CARD) helps them notice jaundice in their newborn and seek hospital care sooner. 128 healthy babies born at 36-42 weeks will be enrolled. One group gets the card and training; the other gets only routine advice. Researchers will track hospital visits for jaundice and breastfeeding success.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Skin Color Scale Material (S-CARD / Neonatal Jaundice Monitoring Card)
- What this could lead to
- If it works, this simple card could help families catch dangerous jaundice early at home, reducing complications and hospital delays.
- What could go wrong
- This is a small, early-stage study (128 babies) testing a monitoring tool, not a treatment. The card may not improve outcomes or could cause unnecessary worry.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 128 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
36 to 42 weeks
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Preterm infants born alive between 36-42 weeks of gestation or delivered healthy to their mothers, * Newborns with a birth weight of 2500 grams or more, * Newborns without a history of multiple pregnancy (twins, triplets, etc.), * Newborns with at least one literate parent, * Newborns whose families voluntarily agree to participate in the study and sign the informed consent form. Exclusion Criteria: * Newborns younger than 36 weeks and requiring intensive care, or newborns older than 42 weeks, * Newborns weighing less than 2500 grams at birth, * Newborns requiring postnatal intensive care, * Newborns with congenital anomalies, metabolic diseases, or serious clinical problems, * Newborns whose families wish to withdraw from the study during the follow-up period or whose contact information is unavailable, * Newborns excluded from analysis due to incomplete or erroneous data, * Newborns whose families did not sign the informed consent form.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neonatal jaundice are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.